Acute Haemodynamic Impact of an IV Glucose-injection

Status

Withdrawn

Phases

Phase 2

Study type

Interventional

Source

ClinicalTrials.gov

Registry ID

NCT00426114

Enrollment

Registered

2007-01-24

Start date

Unknown

Completion date

Unknown

Last updated

2021-07-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Peritoneal Dialysis

Brief summary

Patients with peritoneal dialysis will be administered an IV glucose-injection to evaluate the haemodynamic impact of this injection. The patients will be matched with healthy volunteers.

Interventions

DRUGAdministration of an IV glucose-injection

Study design

Allocation

RANDOMIZED

Intervention model

SINGLE_GROUP

Primary purpose

PREVENTION

Masking

NONE

Eligibility

Sex/Gender

ALL

Age

18 Years to No maximum

Healthy volunteers

Yes

Inclusion criteria

* \> 18 years old * Stable clinical condition * Either peritoneal dialysis (at least one month) either matched healthy subject

Exclusion criteria

* Heart Failure * Diabetes requiring insulin treatment

Design outcomes

Primary

Measure	Time frame
Haemodynamic parameters	—
Glycemia	—

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026